
Worldwide over 170 million people are chronically infected with the zzso C virus and hence at high risk to develop fatal liver zzso There is no vaccine available and the standard therapy zzso zzso zzso plus zzso is only effective in zzso of patients and is associated with important zzso The discovery of novel zzso strategies to selectively inhibit zzso replication has long been hindered by the lack of convenient cell culture models for the propagation of zzso This hurdle has been overcome first with the establishment of the zzso zzso system in 1999 and, in 2005, with the development of robust zzso cell culture zzso In recent years also mouse models have been elaborated that will be instrumental in assessing the in zzso efficacy of novel zzso The viral zzso zzso and the viral zzso dependent zzso zzso have shown to be excellent targets for selective zzso zzso Clinical studies with a limited number of zzso zzso and zzso zzso resulted in encouraging zzso However, and not unexpected, zzso evidence suggest that the virus may become rapidly resistant to such zzso Combination therapy of drugs with different mode of action and resistance profiles may thus be zzso Alternative strategies, such as the use of zzso zzso A zzso with potent zzso activity, may prove important, in particular since such compounds may have a resistance profile that is very different from that of zzso or zzso zzso 

